GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Trius Therapeutics, Inc. (TSRX) [hlAlert]

Trius Therapeutics, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of antibiotics for life threatening infections. The Company is developing torezolid phosphate, an intraveneous (IV) and oral antibiotic, for the treatment of serious gram-positive bacterial infections, initially for acute
bacterial skin and skin structure infections (ABSSSI), and subsequently for other indications. The Company initiated its Phase III clinical program for torezolid phosphate for the treatment of ABSSSI in August 2010. In addition, the Company is developing antibiotics for gram-negative infections using its discovery platform under two contracts: one funded by the National Institute of Allergy and Infectious Diseases (NIAID), a part of the National Institutes of Health (NIH) and the other funded by the Defense Threat Reduction Agency (DTRA), a part of the Department of Defense.
( Total: 9 Current Stock Recommendations )
Trius Therapeutics, Inc.   (9)
Hold 22% Buy 78%
Related companies
DARA BIOSCIENCES   (2)
Buy 100%
CELSION CORP   (6)
Buy 100%
China Biologic ...   (4)
Buy 100%
ATHERSYS INC   (7)
Buy 100%
ACURA PHARMACEUTICAL   (2)
Buy 100%
China Pharma   (2)
Buy 100%
BioSpecifics ...   (5)
Buy 100%
Derma Sciences, Inc.   (2)
Buy 100%
Tenax Therapeutics ...   (2)
Buy 100%
ARCA BIOPHARMA INC.   (1)
Buy 100%
Show  

Date (ET)MemberRatingYTD
Gains
 
8/1/2013  
Hold
  
3/25/2013  
Buy
  
8/29/2012  
Buy
  
5/26/2011  
Buy
  
3/29/2011  
Buy
  
11/27/2012  
Buy
  
12/5/2011  
Buy
  
7/31/2013  
Hold
  
9/14/2010  
Buy
  

* As of 8/27/2015 12:00 AM
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy